Search Results - Yu.E. Balykina

Refine Results
  1. 1
    Using indirect comparisons in pharmacoeconomic examination

    Using indirect comparisons in pharmacoeconomic examination by Yu. E. Balykina, A. S. Kolbin

    Published 2015-03-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    TRIALS OF NEW ANTIBACTERIAL AGENTS — ANY PROSPECTS?

    TRIALS OF NEW ANTIBACTERIAL AGENTS — ANY PROSPECTS? by A.S. Kolbin, S.V. Sidorenko, Yu.E. Balykina

    Published 2010-09-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    HARPER — protocol template for real-world trials for evaluating treatment efficacy

    HARPER — protocol template for real-world trials for evaluating treatment efficacy by S. M. Mukhina, M. I. Baranova, Yu. E. Balykina

    Published 2023-01-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital

    Pharmacoeconomical analysis of use of the low-molecular weight heparins for prevention of the venous tromboembolism in the conditions of multidisciplinary hospital by A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina

    Published 2015-03-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD

    PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD by A. S. Kolbin, I. A. Vilum, Yu. E. Balykina, M. A. Proskurin

    Published 2015-03-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE

    HEALTH ECONOMIC ASSESSMENT OF ANTIRHEUMATIC DRUGS IN PATIENTS WITH REUMATHOID ARTHRITIS PROGRESSED AFTER METOTREXATE by A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, Yu. E. Balykina

    Published 2016-12-01
    Get full text
    Article

    Save to List
    Saved in:
  7. 7
    PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMPACT ANALYSIS

    PHARMACOECONOMIC ANALYSIS OF BRENTUXIMAB VEDOTIN THERAPY IN RELAPSED OR REFRACTORY CD30+ SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA IN PATIENTS OVER 18 YEARS OF AGE: HEALTH BUDGET IMP... by A. S. Kolbin, I. A. Vilum, М. A. Proskurin, Yu. E. Balykina

    Published 2017-05-01
    Get full text
    Article

    Save to List
    Saved in:
  8. 8
    BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD

    BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD by A. S. Kolbin, I. A. Vilyum, M. A. Proskurin, Yu. E. Balykina

    Published 2015-06-01
    Get full text
    Article

    Save to List
    Saved in:
  9. 9
    Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study

    Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study by A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina

    Published 2023-11-01
    Get full text
    Article

    Save to List
    Saved in:
  10. 10
    Pharmacoeconomic analysis of fixed-duration targeted therapy regimens for chronic lymphocytic leukemia compared with therapy used until progression or intolerable toxicity

    Pharmacoeconomic analysis of fixed-duration targeted therapy regimens for chronic lymphocytic leukemia compared with therapy used until progression or intolerable toxicity by A. R. Kasimova, A. S. Kolbin, M. A. Proskurin, Yu. E. Balykina

    Published 2022-11-01
    Get full text
    Article

    Save to List
    Saved in:
  11. 11
    Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia

    Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia by I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina

    Published 2018-08-01
    Get full text
    Article

    Save to List
    Saved in:
  12. 12
    Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia

    Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia by I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina

    Published 2018-05-01
    Get full text
    Article

    Save to List
    Saved in:
  13. 13
    A Systematic Review with Meta-Analysis and Indirect Comparison of the Effectiveness of COVID-19 Anti-Interleukin Therapy

    A Systematic Review with Meta-Analysis and Indirect Comparison of the Effectiveness of COVID-19 Anti-Interleukin Therapy by Yu. M. Gomon, A. S. Kolbin, A. M. Fahrutdinova, T. A. Usmanova, F. M. Sultanova, Yu. E. Balykina

    Published 2023-07-01
    Get full text
    Article

    Save to List
    Saved in:
  14. 14
    The socioeconomic burden of meningococcal infection in the Russian Federation

    The socioeconomic burden of meningococcal infection in the Russian Federation by Yu. V. Lobzin, A. S. Kolbin, A. A. Vilnits, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin

    Published 2024-12-01
    Get full text
    Article

    Save to List
    Saved in:
  15. 15
    ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY HOSPITALS)

    ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY... by Yu. M. Gomon, A. S. Kolbin, S. V. Sidorenko, A. M. Kuzhel’, A. V. Repina, Yu. V. Lobzin, Yu. E. Balykina

    Published 2017-08-01
    Get full text
    Article

    Save to List
    Saved in:
  16. 16
    Modeling microbial drug-resistance: from mathematics to pharmacoeconomics

    Modeling microbial drug-resistance: from mathematics to pharmacoeconomics by Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko

    Published 2018-05-01
    Get full text
    Article

    Save to List
    Saved in:
  17. 17
    FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS

    FIRST RUSSIAN TYPE 2 DIABETES MELLITUS SIMULATION MODEL WITH DISCREET EVENTS MODELING. HEALTH-ECONOMIC ANALYSIS by A. S. Kolbin, O. K. Khmelnitskiy, A. A. Kurylev, Yu. E. Balykina, M. A. Proskurin, E. P. Kolpak, M. V. Bure

    Published 2015-03-01
    Get full text
    Article

    Save to List
    Saved in:
  18. 18
    MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016

    MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 by A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum

    Published 2016-04-01
    Get full text
    Article

    Save to List
    Saved in:
  19. 19
    PROBLEMS OF COMPLICATED INTRA-ABDOMINAL INFECTION’S ANTIBACTERIAL TREATMENT IN MULTIDISCIPLINARY HOSPITALS

    PROBLEMS OF COMPLICATED INTRA-ABDOMINAL INFECTION’S ANTIBACTERIAL TREATMENT IN MULTIDISCIPLINARY HOSPITALS by Yu. M. Gomon, A. S. Kolbin, Yu. E. Balykina, M. A. Arepyeva, S. V. Sidorenko, V. V. Strizheletskiy, I. G. Ivanov, Yu. V. Lobzin, О. A. Grinenko

    Published 2017-12-01
    Get full text
    Article

    Save to List
    Saved in:
  20. 20
    Efficiency of Levilimab in patients with moderate and severe COVID-19

    Efficiency of Levilimab in patients with moderate and severe COVID-19 by Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A.  S. Kolbin, M. V. Livshits, T.  A. Usmanova, A. M. Fakhrutdinova, Yu. S.  Konstantinova, A. P. Gubanov

    Published 2023-04-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: